<strong><span id="feed_ttl" style="font-size: medium;">MELA Sciences Inc. (NASDAQ: MELA)</span></strong><span><br /><br /><strong><span style="font-size: medium;">MELA Sciences is a medical device company focused on the commercialization of its flagship product, MelaFind<sup> ® </sup> , and its further design and development. MelaFind is a non-invasive tool to provide additional information to dermatologists during melanoma skin examinations. The device uses light from visible to near-infrared wavelengths to evaluate skin lesions up to 2.5 mm beneath the skin. The device provides information on a lesion's level of morphologic disorganization to provide additional objective information that may be used by dermatologists in the biopsy decision-making process. MelaFind has been approved by the US Food and Drug Administration for use in the US. In addition, MelaFind has received CE Mark approval and is approved for use in the European Union.</span></strong><br /><br /><strong><span style="font-size: medium;">Company Website: <a rel="nofollow" href="http://www.melasciences.com/" target="_blank">http://www.melasciences.com/</a></span></strong></span>